Moderate to Severe Genital Psoriasis
1 competing product in clinical development for Moderate to Severe Genital Psoriasis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tildrakizumab 100 mg + Placebo | Sun Pharmaceutical | Phase 3 | Active | 44 |